Printer Friendly
The Free Library
14,634,461 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Hard to Treat Diseases Incorporated - HTDS - Announces: Additional Testing by University of Colorado's Health Science Center.


Business Editors/Health/Medical Writers/Education Writers

DELRAY BEACH Delray Beach, resort city (1990 pop. 47,181), Palm Beach co., SE Fla., on the Atlantic coast; settled 1895, inc. 1911. Mostly residential, Delray Beach is also the trade center for a citrus-fruit and vegetable-growing region. , Fla.--(BUSINESS WIRE)--Feb. 18, 2004

Hard to Treat Diseases Incorporated (Pink sheets:HTDS HTDS Hanford Thyroid Disease Study
HTDS Holo Transference Dementia Syndrome (Star Trek Voyager)
HTDS Host Terminal Database Server
HTDS Horizontal Tactical Display System
HTDS Hydrofoil Tactical Data System
) announced today that The University of Colorado's Health Science Center ("UCHSC UCHSC University of Colorado Health Sciences Center ") will continue its testing of Tubercin(R) in conjunction with The Denver Veteran's Affairs Medical Center ("Medical Center").

Consultants for the Company had a successful trip to Colorado which culminated with Hard to Treat Diseases Incorporated entering into a bilateral confidential disclosure agreement with The University of Colorado University of Colorado may refer to:
  • University of Colorado at Boulder (flagship campus)
  • University of Colorado at Colorado Springs
  • University of Colorado at Denver and Health Sciences Center
  • University of Colorado system
 and with the Medical Center. The University of Colorado is an FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approved facility with a certified biocontainment level-3 facility approved for work using infectious diseases. UCHSC and the Medical Center have agreed to continue the testing of Tubercin(R) that was initiated by The University of Oklahoma University of Oklahoma, abbreviated OU, is a coeducational public research university located in the U.S. state of Oklahoma. Founded in 1890, it existed in Oklahoma Territory near Indian Territory 17 years before the two became the state of Oklahoma. . As soon as the material transfer agreements, contracts and related documents are signed the Company will disclose the relevant details.

"Tubercin(R) increases the fight against diseases that affect the immune system immune system

Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders.
," stated the President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of HTDS, Mr. Colm J. King. "Testing and research will continue to determine the effects of Tubercin(R) on various types of cancer, aids and hepatitis."

Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations and whether demand for our product and testing service in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 18, 2004
Words:370
Previous Article:Security Biometrics Subsidiary eMedRx Signs Agreement With Health Resources Inc.
Next Article:Bombardier Appoints New President of Bombardier Transportation.



Related Articles
Genes r us. (ethical, social and moral implications of genetic research)
Ginkgo Biloba.(Pamphlet)
Estrogen and Alzheimer's Disease.(Pamphlet)
Avonex and Copaxone?
Plague Linked to Precipitation.
Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease.
Disease rages behind bars.(Health)(Penitentiary inmates sue to get treatment for hepatitis C)
New center to tackle environmental causes of disease, gaps in environmental health policy.(EH Update)
Schwartz named new NIEHS/NTP director.(Environews / NIEHS News)
Cracking the genomics code: genetic research isn't just for prime-time dramas or high-profile criminal cases. Here's how African American DNA...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles